Stock screenerAll disclosures →
EDGAR →
EWTX
Conviction 53HealthcareScan · Thu, Sep 24, 2026Edgewise Therapeutics, Inc. (EWTX) closed at $41.16 (+0.27%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 41, RS Rating 96, -14.9% from its 52-week high, +73.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
EWTX$41.16+0.27%
ResistanceSupportVol 14Insider sell18
Vol MA14 1.66M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price41.16
Change+0.27%
Gap-0.27%
Rel volume1.63×
Avg volume1.46M
Avg $ vol63.56M
SMA 2043.49
SMA 5042.74
SMA 20034.31
Price vs 50-3.70%
Price vs 200+19.98%
MA stackmixed
50/200 cross—
Supertrendup · 40.60
RSI (14)41
MACD hist-0.35
MACD crossbear · 1d
Stoch %K / %D17 / 26
ADX (14)15
+DI / −DI21 / 28
RSI divergence—
MACD divergence—
ATR %5.47%
ADR %4.75%
52w high48.35
52w low14.70
From 52w high-14.87%
Above 52w low+180.00%
New 52w highNo
SqueezeOn · 19d
Bollinger width13.91%
%B0.11
Donchian pos16.71%
Donchian high48.51
Donchian low39.69
AVWAP (52w high)44.09
vs AVWAP high-6.65%
AVWAP (52w low)32.50
vs AVWAP low+26.64%
OBV trendDown
Chaikin MF (20)-0.11
Today vs 20d1.63×
Avg vol (14d)1.66M
Avg vol (20d)1.46M
Avg $ vol (20d)63.56M
Market cap4.47B
RS Rating96 / 99
RS 3m (vs SPY)-5.76%
RS 6m (vs SPY)+12.05%
RS line new highNo
Trend template6/8
Technical rank65.9
1 week-12.31%
1 month-6.90%
3 months-1.27%
6 months+28.87%
1 year+172.76%
YTD+73.31%
P/E-26.64
P/B9.98
P/S—
P/FCF-31.03
EPS-1.63
Div yield—
ROE-37.45%
ROA-34.98%
Debt/Eq0.00
Current16.24
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-25.40%
Price target50.89
Target upside23.64%
Analyst ratingBuy
Institutional120.66%
Ent. value4.4B
Revenue—
Net income-57.33M
Gross profit—
Free cash flow-144.07M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out107.59M
Employees154
ListedFri, Mar 26, 2021
Free float73.54M
Float %69.5%
Short interest9.35M
Days to cover8.0d
Short volume51.0%
Squeeze score67 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.53 vs −$0.48
Last surprise-10.4% miss
Setup gradeC
Conviction53 / 100
Pattern quality—
Tech rank65.9 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance47.55
Support38.76
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Edgewise Therapeutics Tumbles as Excitement Suddenly FadesTipRanks · Wed, Sep 23, 2026
- EWTX Oct 2026 48.000 call (EWTX261016C00048000) stock historical prices and dataYahoo Finance Singapore · Wed, Sep 23, 2026
- Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & HistoryYahoo! Finance Canada · Tue, Sep 22, 2026
- Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500 - Slideshow (NASDAQ:EWTX) 2026-09-22Seeking Alpha · Tue, Sep 22, 2026
- Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500Yahoo Finance · Tue, Sep 22, 2026
- Edgewise screened more than 7,000 candidates for a heart treatment. EDG-7500 improved relaxation in early tests.Stock Titan · Tue, Sep 22, 2026
- EWTX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00GuruFocus · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in EWTX
No recent disclosed trades by Congress in EWTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EWTX · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Derakhshan Behrad Chief Business Officer · Stock Option (Right to Buy) · 2026-08-12 | Grant | 100K | — | 2026-08-12 | 2026-08-17 |
Donovan Joanne M. CMO · Stock Option (Right to Buy) · 2026-08-12 | Grant | 65K | — | 2026-08-12 | 2026-08-17 |
Nofi Michael Chief Financial Officer · Stock Option (Right to Buy) · 2026-08-12 | Grant | 48.75K | — | 2026-08-12 | 2026-08-17 |
Russell Alan J Chief Scientific Officer · Stock Option (Right to Buy) · 2026-08-12 | Grant | 65K | — | 2026-08-12 | 2026-08-17 |
MOORE JOHN R General Counsel · Stock Option (Right to Buy) · 2026-08-12 | Grant | 65K | — | 2026-08-12 | 2026-08-17 |
Donovan Joanne M. CMO · Common Stock · 2026-08-13 | Sell | 2.92K | $127K | 2026-08-13 | 2026-08-14 |
Derakhshan Behrad Chief Business Officer · Common Stock · 2026-08-12 | Sell | 150 | $7K | 2026-08-12 | 2026-08-14 |
Derakhshan Behrad Chief Business Officer · Common Stock · 2026-08-12 | Sell | 2.48K | $108K | 2026-08-12 | 2026-08-14 |
Derakhshan Behrad Chief Business Officer · Restricted Stock Units · 2026-08-12 | Exercise | 5.78K | — | 2026-08-12 | 2026-08-14 |
Derakhshan Behrad Chief Business Officer · Restricted Stock Units · 2026-08-12 | Exercise | 7.5K | — | 2026-08-12 | 2026-08-14 |
SEC filings
EDGAR filings in EWTX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.